## UDR: UDR, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 2.2% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($34.83)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Truist Securities lowers UDR stock price target to $41 on mixed outlook**
- Source: Investing.com UK | 20251201T142600 | Neutral | Relevance: 98%
- Truist Securities lowered its price target for UDR, Inc. (NYSE:UDR) to $41 from $43 while maintaining a Hold rating, despite the company's third-quarter 2025 earnings beat. This adjustment considers UDR's modest revenue growth, attractive dividend yield, and underperformance against the VNQ index, alongside concerns about slowing employment growth affecting the apartment REIT sector. RBC Capital also recently lowered its price target for UDR to $38.00 from $40.00.

**2. United Dominion Realty Trust, Inc. (NYSE:UDR) Receives Consensus Rating of "Hold" from Analysts**
- Source: MarketBeat | 20251130T222204 | Neutral | Relevance: 98%
- United Dominion Realty Trust, Inc. (NYSE:UDR) has received a consensus "Hold" rating from eighteen brokerages, with an average target price of $40.83. The stock exhibits a high PE ratio and its dividend payout ratio raises sustainability concerns. Several research firms have recently adjusted their ratings and price targets for UDR.

**3. Truist Securities lowers UDR stock price target to $41 on mixed outlook**
- Source: Investing.com | 20251201T092400 | Neutral | Relevance: 98%
- Truist Securities has reduced its price target for UDR, Inc. to $41 from $43, maintaining a Hold rating despite the company's third-quarter 2025 earnings beat and a 2.1% increase in its 2025 NFFO estimate. The adjustment reflects concerns about slowing employment growth affecting the apartment REIT sector and UDR's current valuation challenges, including an elevated P/E ratio. RBC Capital also lowered its price target for UDR to $38 due to declining leasing spreads, indicating a mixed analyst outlook.

**4. Does Analyst Caution on UDR (UDR) Reveal Shifting Confidence in Real Estate Resilience?**
- Source: Simply Wall Street | 20251130T003645 | Neutral | Relevance: 98%
- In late November 2025, research firms lowered their expectations for UDR, reflecting caution towards its near-term prospects despite the company raising its full-year earnings guidance in October. This shift in analyst sentiment is attributed to ongoing market and economic challenges in the real estate sector and the risk of oversupply in key markets, while UDR's core operations show resilience. Investors should consider these varied perspectives, including community fair value estimates and Simply Wall St's comprehensive analysis.

**5. Does Analyst Caution on UDR (UDR) Reveal Shifting Confidence in Real Estate Resilience?**
- Source: Simply Wall Street | 20251130T005014 | Neutral | Relevance: 97%
- Several major research firms lowered their expectations for UDR in late November 2025, maintaining mixed recommendations due to economic challenges in the real estate sector. Despite this caution, UDR raised its full-year earnings guidance in October, highlighting resilience in its operations and maintaining focus on occupancy and rent growth as key catalysts. The article discusses how this analyst caution and sector headwinds could impact UDR's investment narrative, alongside varying fair value estimates from the Simply Wall St Community.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | Truist Securiti | $41 | $43 | -5% |
| 2025-11-25 | Barclays | $44 | $45 | -2% |
| 2025-11-24 | Mizuho | $38 | $40 | -5% |
| 2025-11-13 | Morgan Stanley | $44 | $44 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | Truist Securiti | main | Hold |
| 2025-11-25 | Barclays | main | Overweight |
| 2025-11-24 | Mizuho | main | Neutral |
| 2025-11-13 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.25M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.2% (-0.7%)
- Blackrock Inc.: 9.9% (+0.5%)
- Cohen & Steers Inc.: 8.0% (+1.7%)
- State Street Corpora: 6.6% (+2.2%)
- FMR, LLC: 4.8% (+5.4%)

### Key Risks

1. Long-term trend broken: trading 9.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Analyst sentiment negative (4 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.3B |
| Beta | 0.71 |
| 52W Range | $32.94 - $46.47 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -4.53 |
| Forward P/E | 64.4 |
| Current P/E | 59.9 |
| YoY Growth | -7.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.5% to 2.2% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.8pp (needs >4.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Outperforming sector by 3.1pp, stock-specific strength. Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.24% (CS: 75) | Neutral |
| RSI_14 | 59.3 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.033x | Above |
| vs SMA50 | 1.012x | Above |
| vs SMA200 | 0.908x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $36.09
- **Stop Loss:** $34.83 (3.5% risk)
- **Target:** $37.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 396
- **Position Value:** $14,291.64
- **Portfolio %:** 14.29%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-04 (Est: $0.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.13 | $0.12 | -6.3% |
| 2025Q2 | $0.13 | $0.07 | -49.4% |
| 2025Q1 | $0.11 | $0.18 | +67.3% |
| 2024Q4 | $0.03 | $0.03 | -8.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*